tiprankstipranks
Polydex Pharmaceuticals Limited (POLXF)
OTHER OTC:POLXF
US Market

Polydex Pharmaceuticals (POLXF) Stock Price & Analysis

4 Followers

POLXF Stock Chart & Stats

Day’s Range$1.99 - $1.99
52-Week Range― - ―
Previous Close$1.98
Volume2.09K
Average Volume (3M)N/A
Market Cap
$6.71M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)N/A
BetaN/A
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding3,432,478
10 Day Avg. Volume938
30 Day Avg. Volume2,304
Standard Deviation0.29
R-Squared0.00687
Alpha0.03
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

POLXF FAQ

What was Polydex Pharmaceuticals Limited’s price range in the past 12 months?
Currently, no data Available
What is Polydex Pharmaceuticals Limited’s market cap?
Currently, no data Available
When is Polydex Pharmaceuticals Limited’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Polydex Pharmaceuticals Limited’s earnings last quarter?
Currently, no data Available
Is Polydex Pharmaceuticals Limited overvalued?
According to Wall Street analysts Polydex Pharmaceuticals Limited’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
    Does Polydex Pharmaceuticals Limited pay dividends?
    Polydex Pharmaceuticals Limited does not currently pay dividends.
    What is Polydex Pharmaceuticals Limited’s EPS estimate?
    Polydex Pharmaceuticals Limited’s EPS estimate for its next earnings report is not yet available.
    How many shares outstanding does Polydex Pharmaceuticals Limited have?
    Currently, no data Available
    What happened to Polydex Pharmaceuticals Limited’s price movement after its last earnings report?
    Currently, no data Available
    Which hedge fund is a major shareholder of Polydex Pharmaceuticals Limited?
    Currently, no hedge funds are holding shares in POLXF
    ---

    Polydex Pharmaceuticals Stock Smart Score

    Company Description

    Polydex Pharmaceuticals Limited

    Polydex Pharmaceuticals Ltd. engages in the manufacture and sale of bulk quantities of dextran and derivative products to large pharmaceutical companies. It develops and market biotechnology-based products for the human pharmaceutical market. The firm focuses on Dextran and derivative products, including Iron Dextran and Dextran Sulphate and other specialty chemicals. The company was founded by Thomas C. Usher on June 14, 1979 and is headquartered in Toronto, Canada.
    ---
    Similar Stocks
    Company
    Price & Change
    Follow
    Aptose Biosciences
    Acelrx
    Bellicum Pharmaceuticals
    Galectin Therapeutics
    Popular Stocks
    ---
    What's Included in PREMIUM?
    Make informed decisions based on Top Analysts' activity
    Know what industry insiders are buying
    Get actionable alerts from top Wall Street Analysts
    Find out before anyone else which stock is going to shoot up
    Get powerful stock screeners & detailed portfolio analysis